

> 


# COAGULOPATHIES

![](https://i.imgur.com/Xw755wS.jpg)

Further coagulation tests (_JAMA_ 2016;316:2146)

• Mixing study: useful if ↑ PT or PTT; mix Pt’s plasma 1:1 with normal plasma and retest

PT/PTT normalizes → factor **deficiency;** PT/PTT remains elevated → factor **inhibitor**

• Coagulation factor levels: useful if mixing study suggests factor deficiency

DIC → all factors consumed; ∴ ↓ factors V and VIII

Liver disease → ↓ all factors _except_ VIII; ∴↓ factor V, normal factor VIII

Vitamin K deficiency → ↓ factors II, VII, IX, X (and protein C, S); ∴ normal V and VIII

• **DIC screen:** fibrinogen (consumed), fibrin degradation products (FDPs, ⊕ due to intense fibrinolysis), D-dimer (more specific FDP test that detects degradation of X-linked fibrin)

Hemophilias (_Lancet_ 2016;388:187)

• X-linked recessive **factor VIII** (hemophilia A) or **factor IX** (hemophilia B) **deficiency**

• Classification: mild (5–25% normal factor activity), moderate (1–5%) or severe (<1%)

• 臨床表現: hematomas, hemarthroses, bruising, bleeding (mucosal, GI, GU)

• Diagnosis: ↑ PTT (normalizes withmixing study), normal PT & vWF, ↓ factor VIII or IX

• Prophylaxis indicated if <1% activity of factor VIII or IX

• Rx: purified/recomb. factor VIII (_NEJM_ 2016;374:2054) or IX; desmopressin (mild dis.); aminocaproic acid; cryo (FVIII); emicizumab (bridges factor IX and X), effective for hemophilia A with and without inhibitors (_NEJM_ 2017;377:809 & 2018;379:811)

Coagulation factor inhibitors (most commonly anti–factor VIII)

• 原因: hemophilia; postpartum; lymphoproliferative & autoimmune disorders; cancers

• Diagnosis: ↑ PTT (does _not_ normalize withmixing study); Bethesda assay quantitates titer

• 治療: if high titer → **recomb. factor VIIa**, porcine factor concentrates, activated

prothrombin complex; for others → high-purity human factor, plasmapheresis,

immunosupp. with steroids, CYC and/or RTX (_Curr Opin Hematol_ 2008;15:451)

Disseminated intravascular coagulation (DIC) (_NEJM_ 2014;370:847)

• 原因: trauma, shock, infection, malignancy (esp. APL), obstetric complications

• Pathogenesis: _massive_ activation of coagulation that overwhelms control mechanisms

### Thrombosis in microvasculature → ischemia + microangiopathic hemolytic anemia

Acute consumption of coagulation factors and platelets → **bleeding**

Chronic DIC → able to compensate by ↑ factors and platelets → **thrombosis**

• Diagnosis: ↑ PT, ↑ PTT, ↓ **fibrinogen** (may be _nl_ b/c acute phase), ⊕ **FDP**/**D-dimer**, ↓ plts, ⊕ schistos, ↑ LDH, ↓ hapto; _chronic_ DIC: ⊕ FDP/D-dimer, variable plts, other labs 正常

• 治療: Rx underlying process; support with **FFP**, **cryo** (goal fbgn >100 mg/dL) & **plts**

Vitamin K deficiency

• 原因: malnutrition, ↓ absorption (antibiotic suppression of vitamin K-producing intestinal flora or malabsorption), liver disease (↓ stores), warfarin

![](https://i.imgur.com/sILoqP7.jpg)

\*Routine monitoring not performed. Mode of excretion: K, kidney; L, liver; RES, reticuloendothelial system. 4F-PCC: prothrombin complex concentrate (FII, VII, IX, X; Protein C & S). Anti-fibrinolytics: tranexamic, aminocaproic acid.
